BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27351215)

  • 1. Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation.
    Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy S; Thorsen L; Arbo I; Jones LW; Aakhus S; Lund MB; Kiserud CE
    Br J Cancer; 2016 Jul; 115(2):178-87. PubMed ID: 27351215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
    Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy SO; Wethal T; Kiserud CE; Samersaw-Lund MB
    Acta Oncol; 2018 Jun; 57(6):773-781. PubMed ID: 29171324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for impaired pulmonary function and cardiorespiratory fitness in very long-term adult survivors of childhood acute lymphoblastic leukemia after treatment with chemotherapy only
    Myrdal OH; Kanellopoulos A; Christensen JR; Ruud E; Edvardsen E; Kongerud J; Sikkeland LI; Lund MB
    Acta Oncol; 2018 May; 57(5):658-664. PubMed ID: 29303026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of cardiorespiratory fitness in very long-term survivors of allogeneic hematopoietic stem cell transplantation: a national cohort study.
    Myrdal OH; Diep PP; Ruud E; Brinch L; Massey RJ; Edvardsen E; Kongerud J; Lund MB; Sikkeland LI
    Support Care Cancer; 2021 Apr; 29(4):1959-1967. PubMed ID: 32827056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.
    Kiserud CE; Fagerli UM; Smeland KB; Fluge Ø; Bersvendsen H; Kvaløy S; Holte H; Dahl AA
    Acta Oncol; 2016 May; 55(5):547-53. PubMed ID: 27123741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.
    Hernæs KH; Smeland KB; Fagerli UM; Kiserud CE
    BMC Cancer; 2021 Feb; 21(1):143. PubMed ID: 33557789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.
    Andreadis C; Schuster SJ; Chong EA; Svoboda J; Luger SM; Porter DL; Tsai DE; Nasta SD; Elstrom RL; Goldstein SC; Downs LH; Mangan PA; Cunningham KA; Hummel KA; Gimotty PA; Siegel DL; Glatstein E; Stadtmauer EA
    Bone Marrow Transplant; 2005 Dec; 36(11):955-61. PubMed ID: 16205727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High dose therapy with autologous stem cell transplantation in patients with Hodgkin's lymphoma: long-term follow-up in patients treated in one center].
    Trnĕný M; Vacková B; Pytlík R; Cieslar P; Válková V; Gasová Z; Kobylka P; Trnková M; Krejcová H; Klener P
    Cas Lek Cesk; 2006; 145(1):19-24. PubMed ID: 16468237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiorespiratory Fitness and Physical Activity following Lung Transplantation: A National Cohort Study.
    Ulvestad M; Durheim MT; Kongerud JS; Hansen BH; Lund MB; Edvardsen E
    Respiration; 2020; 99(4):316-324. PubMed ID: 32272479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.
    Seland M; Smeland KB; Bjøro T; Falk RS; Fosså SD; Gjesdal CG; Godang K; Holte H; Svartberg J; Syversen U; Bollerslev J; Kiserud CE
    Acta Oncol; 2017 Apr; 56(4):590-598. PubMed ID: 28077016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.
    Bersvendsen HS; Haugnes HS; Fagerli UM; Fluge Ø; Holte H; Smeland KB; Wilsgaard T; Kiserud CE
    Acta Oncol; 2019 May; 58(5):690-699. PubMed ID: 30696346
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.
    Armenian SH; Horak D; Scott JM; Mills G; Siyahian A; Berano Teh J; Douglas PS; Forman SJ; Bhatia S; Jones LW
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):700-705. PubMed ID: 28065839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
    Majhail NS; Ness KK; Burns LJ; Sun CL; Carter A; Francisco L; Forman SJ; Bhatia S; Baker KS
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1153-9. PubMed ID: 17889351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome.
    Kumar L; Ganessan P; Ghosh I; Panda D; Gogia A; Mandhania S
    Natl Med J India; 2010; 23(6):330-5. PubMed ID: 21561042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between cardiorespiratory fitness and pulmonary diffusing capacity.
    Zavorsky GS; Smoliga JM
    Respir Physiol Neurobiol; 2017 Jul; 241():28-35. PubMed ID: 28323203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
    Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of high-dose chemotherapy with hematopoietic stem cell transplantation for malignant lymphoma].
    Okamoto M
    Rinsho Ketsueki; 2001 Apr; 42(4):299-306. PubMed ID: 11400301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.